Home


Brain Tumors
This category includes all types of brain tumors.

Trials

A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens (ACNS02B3)
Phase
: Biology Site: Phoenix Status: Open



High dose temozolomide, thiotepa and carboplatin with autologous stem cell rescue followed by continuation therapy with 13-cis-retinoic acid in patients with recurrent/refractory malignant brain tumors (ONC-032P)
Phase
: II Site: Phoenix Status: Open



Study of Conformal Radiotherapy in Patients with Low Grade Gliomas (ACNS0221)
Phase
: II Site: Phoenix Status: Active



Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: Double Randomized Trial (ACNS0331)
Phase
: III Site: Phoenix Status: Open



Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients (ACNS0332)
Phase
: III Site: Phoenix Status: Open



A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate (ACNS0334)
Phase
: III Site: Phoenix Status: Open



A Multi-center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDx5 Every Other Week in Pediatric Patients with Advanced Solid Tumors (AP23573-07-110)
Phase
: I Site: Phoenix Status: Open



A phase II trial of external beam radiation therapy and cetuximab followed by irinotecan and cetuximab for children and young adults with newly diagnosed diffuse pontine tumors and high-grade astrocytomas (POE08-01)
Phase
: II Site: Phoenix Status: Open



A Phase II Study of RAD001 (Everolimus) for Children with Chemotherapy and/or Radiation Refractory Progressive or Recurrent Low-Grade Gliomas (POE09-01)
Phase
: II Site: Phoenix Status: Open



Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma
Phase
: II Site: Phoenix Status: Open



Back to Directory of Trials



© 2009, Phoenix Children's Hospital.